Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Individualized Neurodevelopmental Treatment

This study has been completed.
Sponsor:
Information provided by:
Hellenic Society for Disabled Children
ClinicalTrials.gov Identifier:
NCT00922077
First received: June 1, 2009
Last updated: June 16, 2009
Last verified: June 2009
  Purpose

The purpose of the study was to evaluate this therapeutic intervention by expressing functional level with valid quantitative data.


Condition Intervention Phase
Cerebral Palsy
Behavioral: standard physical therapy program with emphasis on dynamic balance exercises
Phase 3

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Primary Purpose: Treatment
Official Title: Individualized Neurodevelopmental Treatment

Resource links provided by NLM:


Further study details as provided by Hellenic Society for Disabled Children:

Enrollment: 1
Study Start Date: January 2008
Study Completion Date: April 2008
Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
Detailed Description:

The intervention lasted 6 weeks. There were 3 sessions per week. At each session there was a part of standard physical therapy program and there was also a part with emphasis on dynamic balance exercises.

  Eligibility

Ages Eligible for Study:   6 Years to 9 Years
Genders Eligible for Study:   Female
Criteria

Inclusion Criteria:

  • spastic tetraplegia

Exclusion Criteria:

  • vision problems
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00922077

Locations
Greece
Hellenic Society for Disabled Children
Thessaloniki, Greece, 25155
Sponsors and Collaborators
Hellenic Society for Disabled Children
  More Information

No publications provided

Responsible Party: Gait Laboratory ELEPAP THESSALONIKI
ClinicalTrials.gov Identifier: NCT00922077     History of Changes
Other Study ID Numbers: 001-Nikodelis
Study First Received: June 1, 2009
Last Updated: June 16, 2009
Health Authority: Greece: Ministry of Health and Welfare
Greece: Ethics Committee

Additional relevant MeSH terms:
Cerebral Palsy
Brain Damage, Chronic
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on November 24, 2014